Weight Management Medications 

THIS PAGE MUST BE REVIEWED FOR COMPLIANCE

Yes. Our GPs can prescribe semaglutide as part of a medically supervised weight management plan, following a thorough real-time telehealth consultation. See our weight management.
GLP-1s is available in Australia in formulations approved for type 2 diabetes and, separately, for chronic weight management in eligible adults. Which form is appropriate for you is a clinical decision your online GP will make based on your individual health profile.

GLP-1s for weight management is generally considered for adults with a BMI of 30 or above, or a BMI of 27 or above accompanied by a weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. Eligibility is not determined by BMI alone.
During your consultation, your GP will review your full medical history, current medications, and any conditions that may affect whether semaglutide is safe and appropriate for you.
It is not suitable for everyone, and your doctor may recommend alternative treatments or refer you for further assessment.

Your consultation follows the same standard as an in-person GP appointment.
Your doctor will discuss your weight history and previous attempts at management, assess any relevant health conditions, explain how GLP-1s works, outline realistic expectations, and discuss potential side effects.
If GLP-1s is appropriate, they will issue a prescription electronically.
Ongoing monitoring is an important part of treatment. Your doctor will want to review your progress, adjust your dosage as needed, and check that the medication continues to be appropriate for you.

The most frequently reported side effects are gastrointestinal nausea, vomiting, diarrhoea, constipation, and bloating particularly in the early weeks of treatment as your body adjusts. These are usually mild and tend to settle over time.
More serious but less common side effects can occur, which your GP will discuss with you during your consultation.
It is important to contact your doctor if you experience persistent or concerning symptoms. GLP-1s is a clinically significant medication, not a lifestyle supplement, and ongoing medical oversight is essential.

No. Compounded GLP-1s or unregulated versions previously made by some pharmacies have been banned in Australia since October 2024 following safety concerns raised by the TGA.
Our GPs only prescribe TGA-approved GLP-1 products.
These meet Australian standards for safety, quality, and efficacy.
We strongly advise against purchasing GLP-1s from unverified online sources, which may supply counterfeit or unsafe products.

Research indicates that weight lost during GLP-1s treatment may return if the medication is stopped without sustained lifestyle changes in place.
Your GP will work with you to set realistic goals, discuss the long-term nature of weight management, and ensure your treatment plan including diet, activity, and medical follow-up supports lasting results.
Prescribing GLP-1s is always paired with an ongoing clinical relationship, not a one-off transaction.